Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorStanford University
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Available aneuploid or mosaic embryos
No other acceptable embryos available
Willing to travel to Stanford for treatment
English language fluency
Use of international donor eggs or sperm not tested according to FDA guidelines.
Living outside the United States
Embryos with Triploidy are not eligible for transfer in this protocol